Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having Class I membrane fusogenic envelope proteins

Details for Australian Patent Application No. 2004288218 (hide)

Owner The Administrators of the Tulane Educational Fund

Inventors Wilson, Russell B.; Garry, Robert F.

Agent Davies Collison Cave

Pub. Number AU-B-2004288218

PCT Pub. Number WO2005/044992

Priority 60/517,181 04.11.03 US

Filing date 3 November 2004

Wipo publication date 19 May 2005

Acceptance publication date 24 December 2009

International Classifications

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/42 (2006.01) Medicinal preparations containing antigens or antibodies - viral

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/005 (2006.01) Peptides having more than 20 amino acids - from viruses

C07K 16/08 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from viruses

C12Q 1/18 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Testing for antimicrobial activity of a material

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

25 May 2006 PCT application entered the National Phase

  PCT publication WO2005/044992 Priority application(s): WO2005/044992

14 September 2006 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Russell, Wilson to Wilson, Russell B.

24 December 2009 Application Accepted

  Published as AU-B-2004288218

22 April 2010 Standard Patent Sealed

21 July 2011 Assignment Registered

  The Administrators of the Tulane Educational Fund The patent has been assigned to The Administrators of the Tulane Educational Fund; Autoimmune Technologies, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004288222-Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)

2004288217-Compositions and methods of use for a fibroblast growth factor